56 275

Cited 0 times in

Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY)

DC Field Value Language
dc.contributor.authorShao, Z-
dc.contributor.authorPang, D-
dc.contributor.authorYang, H-
dc.contributor.authorLi, W-
dc.contributor.authorWang, S-
dc.contributor.authorCui, S-
dc.contributor.authorLiao, N-
dc.contributor.authorWang, Y-
dc.contributor.authorWang, C-
dc.contributor.authorChang, YC-
dc.contributor.authorWang, H-
dc.contributor.authorKang, SY-
dc.contributor.authorJiang, Z-
dc.contributor.authorLi, J-
dc.contributor.authorZhou, J-
dc.contributor.authorAlthaus, B-
dc.contributor.authorMao, Y-
dc.contributor.authorEng-Wong, J-
dc.date.accessioned2020-11-17T05:33:05Z-
dc.date.available2020-11-17T05:33:05Z-
dc.date.issued2019-
dc.identifier.issn0008-5472-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/19155-
dc.language.isoen-
dc.titlePertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY)-
dc.typeArticle-
dc.contributor.affiliatedAuthor강, 석윤-
dc.type.localJournal Papers-
dc.identifier.doi10.1158/1538-7445.SABCS18-P6-17-17-
dc.citation.titleCancer research-
dc.citation.volume79-
dc.citation.number4S-
dc.citation.date2019-
dc.citation.startPageP6-17-17-
dc.citation.endPageP6-17-17-
dc.identifier.bibliographicCitationCancer research, 79(4S). : P6-17-17-P6-17-17, 2019-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn1538-7445-
dc.relation.journalidJ000085472-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Files in This Item:
10.1158_1538-7445.SABCS18-P6-17-17.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse